Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|March 15, 2006
Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical studyEwa Chmielik, Krzysztof Bujko, Anna Nasierowska-Guttmejer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excisionKrzysztof Bujko, Marek P Nowacki, Anna Nasierowska-Guttmejer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2007
Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trialLucyna Pietrzak, Krzysztof Bujko, Marek P Nowacki, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyK Bujko, M P Nowacki, A Nasierowska-Guttmejer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2009
Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor respondersKrzysztof Bujko, Piotr Richter, Milena Kołodziejczyk, et al.Cell Death & Disease|January 11, 2014
PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYNL Liu, Q Wen, R Gong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsHans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.Blood|August 15, 2019
Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesisTe Ling, Yehudit Birger, Monika J Stankiewicz, et al.Leukemia|June 11, 2013
AKT is a therapeutic target in myeloproliferative neoplasmsI Khan, Z Huang, Q Wen, et al.Pageof 17